Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-25-009676
Filing Date
2025-03-20
Accepted
2025-03-20 16:01:44
Documents
5
Effectiveness Date
2025-03-20

Document Format Files

Seq Description Document Type Size
1 S-8 ef20045895_s8.htm S-8 41537
2 EXHIBIT 5.1 ef20045895_ex5-1.htm EX-5.1 7604
3 EXHIBIT 23.1 ef20045895_ex23-1.htm EX-23.1 2421
4 EXHIBIT 107.1 ef20045895_ex107-1.htm EX-FILING FEES 12997
5 image0.jpg GRAPHIC 34999
  Complete submission text file 0001140361-25-009676.txt   114113
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285954 | Film No.: 25756371
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)